GH Research (STU:1KA) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is GH Research FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. GH Research's Free Cash Flow for the three months ended in Dec. 2024 was €-10.00 Mil. GH Research's Revenue for the three months ended in Dec. 2024 was €0.00 Mil. Therefore, GH Research's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, GH Research's current FCF Yield % is -5.59%.

The historical rank and industry rank for GH Research's FCF Margin % or its related term are showing as below:

STU:1KA's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -143.22
* Ranked among companies with meaningful FCF Margin % only.

GH Research FCF Margin % Historical Data

The historical data trend for GH Research's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research FCF Margin % Chart

GH Research Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

GH Research Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of GH Research's FCF Margin %

For the Biotechnology subindustry, GH Research's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GH Research's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GH Research's FCF Margin % distribution charts can be found below:

* The bar in red indicates where GH Research's FCF Margin % falls into.

GH Research FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

GH Research's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-40.429	/	0
	=	%

GH Research's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-10	/	0
	=	%

GH Research FCF Margin % Related Terms

Thank you for viewing the detailed overview of GH Research's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

GH Research Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (STU:1KA) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

GHRS:USA

Address

Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95

Website

https://www.ghres.com

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

GH Research Headlines

No Headlines